TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: TAHLC - Texting to Promote Adolescent Health Liaisons and Chronic Disease Management
Brief Summary: UCSD researchers are conducting a study aimed to develop and evaluate a chronic disease self management web and text message based program on health-related self-efficacy and frequency of adolescent-conducted healthcare interactions. We hypothesize that users of the program will demonstrate greater gains between baseline and 8 month measures of health related self-efficacy and adolescent-conducted healthcare interactions as compared to the usual care comparison group.


Options:
A: Arm Label: SMS and Internet; Type: EXPERIMENTAL; Interventions: Behavioral: MD2ME | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MD2ME; Assigned to Arm(s): SMS and Internet
B: Intervention Type: DRUG; Name: hypertonic saline; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Supervised aerobic training; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Supervised strength training; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Unsupervised training; Assigned to Arm(s): N/A
D: Arm Label: Placebo (pooled two times a day [BID]/three times a day [TID]); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo two times a day (BID)/three times a day (TID) | Arm Label: AZLI (pooled two times a day [BID]/three times a day [TID]); Type: EXPERIMENTAL; Interventions: Drug: AZLI 75 mg two times a day (BID)/three times a day (TID) | Intervention Type: DRUG; Name: AZLI 75 mg two times a day (BID)/three times a day (TID); Assigned to Arm(s): AZLI (pooled two times a day [BID]/three times a day [TID]) | Intervention Type: DRUG; Name: Placebo two times a day (BID)/three times a day (TID); Assigned to Arm(s): Placebo (pooled two times a day [BID]/three times a day [TID])

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: TAHLC - Texting to Promote Adolescent Health Liaisons and Chronic Disease Management
Brief Summary: UCSD researchers are conducting a study aimed to develop and evaluate a chronic disease self management web and text message based program on health-related self-efficacy and frequency of adolescent-conducted healthcare interactions. We hypothesize that users of the program will demonstrate greater gains between baseline and 8 month measures of health related self-efficacy and adolescent-conducted healthcare interactions as compared to the usual care comparison group.


Options:
A: Arm Label: Placebo (pooled two times a day [BID]/three times a day [TID]); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo two times a day (BID)/three times a day (TID) | Arm Label: AZLI (pooled two times a day [BID]/three times a day [TID]); Type: EXPERIMENTAL; Interventions: Drug: AZLI 75 mg two times a day (BID)/three times a day (TID) | Intervention Type: DRUG; Name: AZLI 75 mg two times a day (BID)/three times a day (TID); Assigned to Arm(s): AZLI (pooled two times a day [BID]/three times a day [TID]) | Intervention Type: DRUG; Name: Placebo two times a day (BID)/three times a day (TID); Assigned to Arm(s): Placebo (pooled two times a day [BID]/three times a day [TID])
B: Intervention Type: BEHAVIORAL; Name: Decision Aid; Assigned to Arm(s): N/A
C: Arm Label: Usual Support Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual-Support | Arm Label: Enhanced Support Group; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Support | Intervention Type: BEHAVIORAL; Name: Enhanced Support; Assigned to Arm(s): Enhanced Support Group | Intervention Type: BEHAVIORAL; Name: Usual-Support; Assigned to Arm(s): Usual Support Group
D: Arm Label: SMS and Internet; Type: EXPERIMENTAL; Interventions: Behavioral: MD2ME | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MD2ME; Assigned to Arm(s): SMS and Internet

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: TAHLC - Texting to Promote Adolescent Health Liaisons and Chronic Disease Management
Brief Summary: UCSD researchers are conducting a study aimed to develop and evaluate a chronic disease self management web and text message based program on health-related self-efficacy and frequency of adolescent-conducted healthcare interactions. We hypothesize that users of the program will demonstrate greater gains between baseline and 8 month measures of health related self-efficacy and adolescent-conducted healthcare interactions as compared to the usual care comparison group.


Options:
A: Arm Label: Placebo (pooled two times a day [BID]/three times a day [TID]); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo two times a day (BID)/three times a day (TID) | Arm Label: AZLI (pooled two times a day [BID]/three times a day [TID]); Type: EXPERIMENTAL; Interventions: Drug: AZLI 75 mg two times a day (BID)/three times a day (TID) | Intervention Type: DRUG; Name: AZLI 75 mg two times a day (BID)/three times a day (TID); Assigned to Arm(s): AZLI (pooled two times a day [BID]/three times a day [TID]) | Intervention Type: DRUG; Name: Placebo two times a day (BID)/three times a day (TID); Assigned to Arm(s): Placebo (pooled two times a day [BID]/three times a day [TID])
B: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Home monitoring; Type: ACTIVE_COMPARATOR; Interventions: Device: Home lung function and symptom monitoring | Intervention Type: DEVICE; Name: Home lung function and symptom monitoring; Assigned to Arm(s): Home monitoring
C: Arm Label: SMS and Internet; Type: EXPERIMENTAL; Interventions: Behavioral: MD2ME | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MD2ME; Assigned to Arm(s): SMS and Internet
D: Arm Label: Home monitoring; Type: EXPERIMENTAL; Interventions: Procedure: Home Monitoring | Arm Label: Clinical Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Clinical Care | Intervention Type: PROCEDURE; Name: Home Monitoring; Assigned to Arm(s): Home monitoring | Intervention Type: OTHER; Name: Clinical Care; Assigned to Arm(s): Clinical Care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: TAHLC - Texting to Promote Adolescent Health Liaisons and Chronic Disease Management
Brief Summary: UCSD researchers are conducting a study aimed to develop and evaluate a chronic disease self management web and text message based program on health-related self-efficacy and frequency of adolescent-conducted healthcare interactions. We hypothesize that users of the program will demonstrate greater gains between baseline and 8 month measures of health related self-efficacy and adolescent-conducted healthcare interactions as compared to the usual care comparison group.


Options:
A: Arm Label: Intrinsic Motivation; Type: EXPERIMENTAL; Interventions: Behavioral: MI + CATCH-IT Internet Site | Arm Label: Extrinsic Motivation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: BA (brief advice) + CATCH-IT Internet site | Intervention Type: BEHAVIORAL; Name: MI + CATCH-IT Internet Site; Assigned to Arm(s): Intrinsic Motivation | Intervention Type: BEHAVIORAL; Name: BA (brief advice) + CATCH-IT Internet site; Assigned to Arm(s): Extrinsic Motivation
B: Arm Label: Clinic-based Educational Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Clinic-based Educational Intervention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Clinic-based Educational Intervention; Assigned to Arm(s): Clinic-based Educational Intervention
C: Intervention Type: BEHAVIORAL; Name: Screening (Behavior); Assigned to Arm(s): N/A
D: Arm Label: SMS and Internet; Type: EXPERIMENTAL; Interventions: Behavioral: MD2ME | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MD2ME; Assigned to Arm(s): SMS and Internet

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Glucose 25% and Facilitated Tucking for Reducing Procedural Stress During Neonatologist-performed Cardiac Echocardiography in Infants in the NICU
Brief Summary: The purpose of this study is to compare the effect of a 25% glucose solution given via a soother with or without facilitated tucking with a similarly administered water placebo (control condition) on infant stress responses during and immediately after a neonatologist performed ECHO (np-ECHO).


Options:
A: Arm Label: Oral Glucose with soother; Type: ACTIVE_COMPARATOR; Interventions: Drug: Glucose 25% oral solution | Arm Label: Oral water with soother; Type: PLACEBO_COMPARATOR; Interventions: Other: Oral water | Arm Label: Oral glucose with soother and tucking; Type: ACTIVE_COMPARATOR; Interventions: Drug: Glucose 25% oral solution | Arm Label: Oral water with soother and tucking; Type: PLACEBO_COMPARATOR; Interventions: Other: Oral water | Intervention Type: DRUG; Name: Glucose 25% oral solution; Assigned to Arm(s): Oral Glucose with soother, Oral glucose with soother and tucking | Intervention Type: OTHER; Name: Oral water; Assigned to Arm(s): Oral water with soother, Oral water with soother and tucking
B: Arm Label: Maternal voice; Type: EXPERIMENTAL; Interventions: Other: Maternal voice | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Maternal voice; Assigned to Arm(s): Maternal voice
C: Arm Label: Standard Care; Type: SHAM_COMPARATOR; Interventions: Behavioral: Be Sweet to Babies Videos and Pamphlet | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: MIAS&Q, Behavioral: Be Sweet to Babies Videos and Pamphlet | Intervention Type: BEHAVIORAL; Name: MIAS&Q; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Be Sweet to Babies Videos and Pamphlet; Assigned to Arm(s): Intervention, Standard Care
D: Arm Label: Breastfeeding; Type: EXPERIMENTAL; Interventions: Other: Breastfeeding | Arm Label: 24% oral sucrose; Type: ACTIVE_COMPARATOR; Interventions: Drug: 24% oral sucrose | Intervention Type: OTHER; Name: Breastfeeding; Assigned to Arm(s): Breastfeeding | Intervention Type: DRUG; Name: 24% oral sucrose; Assigned to Arm(s): 24% oral sucrose

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mindfulness for Symptom Reduction: A Transplant Candidate Study in Program Grant Studies of Organ Transplantation in Animals and Man 2P01 DK013083
Brief Summary: The purpose of this study is to determine whether telephone-adapted Mindfulness Based Stress Reduction (tMBSR) - a program of mindfulness meditation and gentle Hatha yoga delivered mostly by phone, is an effective program to reduce symptoms (anxiety, depression, sleep) and improve quality of life for people waiting for a kidney transplant. Participants will be randomly assigned to tMBSR or to a support group emphasizing communication skills and selecting resources. Both 8-week programs include an initial in-person meeting, 6 weekly teleconference calls, and conclude with an in-person meeting. Participants will complete questionnaires at 3 timepoints over 6 months, and if they receive a transplant, will complete additional questionnaires. Participants will complete sleep diaries and wear Actiwatches (similar to a wristwatch) for one week before programs start, and when programs end, to measure sleep. Participants will provide saliva samples, over 3 days before programs start, and again when programs end, to measure salivary cortisol, an indicator of stress. tMBSR participants will record daily home meditation practice.


Options:
A: Intervention Type: DRUG; Name: epoetin alfa; Assigned to Arm(s): N/A
B: Arm Label: CBT-I; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia | Arm Label: Medication- Trazodone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Trazodone | Arm Label: Medication- Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for Insomnia; Assigned to Arm(s): CBT-I | Intervention Type: DRUG; Name: Trazodone; Assigned to Arm(s): Medication- Trazodone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Medication- Placebo
C: Arm Label: tMBSR; Type: EXPERIMENTAL; Interventions: Behavioral: tMBSR | Arm Label: Support Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Support group | Intervention Type: BEHAVIORAL; Name: tMBSR; Assigned to Arm(s): tMBSR | Intervention Type: BEHAVIORAL; Name: Support group; Assigned to Arm(s): Support Group
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Energy conservation education intervention for people with end-stage kidney disease receiving hemodialysis | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Energy conservation education intervention for people with end-stage kidney disease receiving hemodialysis; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mindfulness for Symptom Reduction: A Transplant Candidate Study in Program Grant Studies of Organ Transplantation in Animals and Man 2P01 DK013083
Brief Summary: The purpose of this study is to determine whether telephone-adapted Mindfulness Based Stress Reduction (tMBSR) - a program of mindfulness meditation and gentle Hatha yoga delivered mostly by phone, is an effective program to reduce symptoms (anxiety, depression, sleep) and improve quality of life for people waiting for a kidney transplant. Participants will be randomly assigned to tMBSR or to a support group emphasizing communication skills and selecting resources. Both 8-week programs include an initial in-person meeting, 6 weekly teleconference calls, and conclude with an in-person meeting. Participants will complete questionnaires at 3 timepoints over 6 months, and if they receive a transplant, will complete additional questionnaires. Participants will complete sleep diaries and wear Actiwatches (similar to a wristwatch) for one week before programs start, and when programs end, to measure sleep. Participants will provide saliva samples, over 3 days before programs start, and again when programs end, to measure salivary cortisol, an indicator of stress. tMBSR participants will record daily home meditation practice.


Options:
A: Arm Label: Bright Light Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Bright Light Therapy | Arm Label: Wait-list intervention; Type: OTHER; Interventions: Behavioral: Wait-list intervention | Intervention Type: BEHAVIORAL; Name: Bright Light Therapy; Assigned to Arm(s): Bright Light Therapy | Intervention Type: BEHAVIORAL; Name: Wait-list intervention; Assigned to Arm(s): Wait-list intervention
B: Arm Label: tMBSR; Type: EXPERIMENTAL; Interventions: Behavioral: tMBSR | Arm Label: Support Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Support group | Intervention Type: BEHAVIORAL; Name: tMBSR; Assigned to Arm(s): tMBSR | Intervention Type: BEHAVIORAL; Name: Support group; Assigned to Arm(s): Support Group
C: Arm Label: extended hours; Type: EXPERIMENTAL; Interventions: Procedure: haemodialysis | Arm Label: standard hours; Type: ACTIVE_COMPARATOR; Interventions: Procedure: haemodialysis | Intervention Type: PROCEDURE; Name: haemodialysis; Assigned to Arm(s): extended hours, standard hours
D: Arm Label: Auricular acupressure therapy; Type: EXPERIMENTAL; Interventions: Other: auricular acupressure therapy | Arm Label: sham auricular acupressure therapy; Type: SHAM_COMPARATOR; Interventions: Other: sham auricular acupressure therapy | Intervention Type: OTHER; Name: auricular acupressure therapy; Assigned to Arm(s): Auricular acupressure therapy | Intervention Type: OTHER; Name: sham auricular acupressure therapy; Assigned to Arm(s): sham auricular acupressure therapy

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Efficacy of Adductor-Canal-Block (ACB) in Patients After Knee Arthroscopy
Brief Summary: The Purpose of this study is to determine whether Adductor-Canal-Block (ACB) is superior to placebo when it comes to analgetic efficacy after Knee-Arthroscopy.


Options:
A: Arm Label: Arm RP; Type: OTHER; Interventions: Drug: Ropivacaine, Drug: Saline | Arm Label: Arm PR; Type: OTHER; Interventions: Drug: Ropivacaine, Drug: Saline | Intervention Type: DRUG; Name: Ropivacaine; Assigned to Arm(s): Arm PR, Arm RP | Intervention Type: DRUG; Name: Saline; Assigned to Arm(s): Arm PR, Arm RP
B: Arm Label: Adductor-Canal-Block, Ropivacain; Type: EXPERIMENTAL; Interventions: Procedure: Adductor-Canal-Block, Ropivacain | Arm Label: Adductor-Canal-Block (ACB) - Saline; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Adductor Canal Block, Placebo (saline) | Intervention Type: PROCEDURE; Name: Adductor-Canal-Block, Ropivacain; Assigned to Arm(s): Adductor-Canal-Block, Ropivacain | Intervention Type: PROCEDURE; Name: Adductor Canal Block, Placebo (saline); Assigned to Arm(s): Adductor-Canal-Block (ACB) - Saline
C: Arm Label: Adductor-Canal-Blockade with Ropivacaine; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Adductor-Canal-Blockade with Ropivacaine | Arm Label: Adductor-Canal-blockade with saline; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Adductor-Canal-blockade with saline | Intervention Type: PROCEDURE; Name: Adductor-Canal-Blockade with Ropivacaine; Assigned to Arm(s): Adductor-Canal-Blockade with Ropivacaine | Intervention Type: PROCEDURE; Name: Adductor-Canal-blockade with saline; Assigned to Arm(s): Adductor-Canal-blockade with saline
D: Arm Label: Local Inflitration Only; Type: PLACEBO_COMPARATOR; Interventions: Drug: Local Infiltration | Arm Label: Adductor Canal Block; Type: ACTIVE_COMPARATOR; Interventions: Drug: Adductor Canal Block | Arm Label: Adductor Canal Block with Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Adductor Canal Block with Morphine | Intervention Type: DRUG; Name: Adductor Canal Block; Assigned to Arm(s): Adductor Canal Block | Intervention Type: DRUG; Name: Adductor Canal Block with Morphine; Assigned to Arm(s): Adductor Canal Block with Morphine | Intervention Type: DRUG; Name: Local Infiltration; Assigned to Arm(s): Local Inflitration Only

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mobilizing Evidence Into Action to Improve Outcomes of Vulnerable Seniors
Brief Summary: This is a parallel Randomized Controlled Trial comparing two different delivery modes of post hip fracture management-a specialized Fracture Follow-up Clinic versus Usual Care alone. The Fracture Follow-up Clinic will focus on bone health and fall risk factors. The investigators will evaluate the effect of the clinic and exercise program on mobility and falls. The investigators primary hypothesis is that within the first year following a hip fracture, older adults who are assessed in the B4 Clinic and prescribed an exercise program will have significantly improved Short Physical Performance Battery (SPPB) scores compared with participants who receive usual care alone.


Options:
A: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: B4 Clinic | Intervention Type: OTHER; Name: B4 Clinic; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
B: Arm Label: Orthogeriatric unit; Type: EXPERIMENTAL; Interventions: Procedure: geriatric work-up | Arm Label: Orthopedic care as usual; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Orthopedic care as usual | Intervention Type: PROCEDURE; Name: geriatric work-up; Assigned to Arm(s): Orthogeriatric unit | Intervention Type: PROCEDURE; Name: Orthopedic care as usual; Assigned to Arm(s): Orthopedic care as usual
C: Intervention Type: PROCEDURE; Name: Orthogeriatric intervention; Assigned to Arm(s): N/A
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Subacute care group; Type: OTHER; Interventions: Other: Subacute care | Arm Label: Comprehensive care group; Type: EXPERIMENTAL; Interventions: Other: Comprehensive care | Intervention Type: OTHER; Name: Comprehensive care; Assigned to Arm(s): Comprehensive care group | Intervention Type: OTHER; Name: Subacute care; Assigned to Arm(s): Subacute care group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 4, Randomized, 52-Week Study To Evaluate Two Assessment Tools To Predict Treatment Success At 52 Weeks Based On A Treatment Decision At Week 12 In Subjects With Moderate To Severe Rheumatoid Arthritis Receiving Cimzia
Brief Summary: Phase 4 study to evaluate a routine patient completed assessment (RAPID3) compared to a physician completed assessment (CDAI) to predict treatment success with subjects with moderate to severe rheumatoid arthritis


Options:
A: Arm Label: RAPID3 to assess response to Cimzia; Type: OTHER; Interventions: Biological: Certolizumab Pegol (CZP) | Arm Label: CDAI to assess response to Cimzia; Type: OTHER; Interventions: Biological: Certolizumab Pegol (CZP) | Intervention Type: BIOLOGICAL; Name: Certolizumab Pegol (CZP); Assigned to Arm(s): CDAI to assess response to Cimzia, RAPID3 to assess response to Cimzia
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Cimzia; Type: EXPERIMENTAL; Interventions: Biological: Certolizumab pegol | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BIOLOGICAL; Name: Certolizumab pegol; Assigned to Arm(s): Cimzia
C: Arm Label: CDP870 200mg; Type: EXPERIMENTAL; Interventions: Drug: CDP870 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo of CDP870 | Intervention Type: DRUG; Name: CDP870; Assigned to Arm(s): CDP870 200mg | Intervention Type: DRUG; Name: Placebo of CDP870; Assigned to Arm(s): Placebo
D: Arm Label: Certolizumab pegol 400 mg and placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Certolizumab pegol, Other: Placebo | Arm Label: Certolizumab pegol 200 mg and placebo; Type: EXPERIMENTAL; Interventions: Drug: Certolizumab pegol, Other: Placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Certolizumab pegol; Assigned to Arm(s): Certolizumab pegol 400 mg and placebo | Intervention Type: DRUG; Name: Certolizumab pegol; Assigned to Arm(s): Certolizumab pegol 200 mg and placebo | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Certolizumab pegol 200 mg and placebo, Certolizumab pegol 400 mg and placebo, Placebo

Answer: A